公司资料
Catheter Precision 股价、新闻与催化剂
- 股票代码:
- VTAK
- 交易所:
- NYSE
- 行业:
- MedTech
- 所在地:
- United States
股票表现
0.15 USD (+1.33%)
收盘价
最后更新: 2026年10月1日
2.58M USD
市值
股价为何变动
最新监测到的公司动态为“Flyte Aviation Launches Under NYSE American Ticker “VJET””。相应的收盘价反应尚未产生。
公司概览
Cardiac Electrophysiology and Aviation Company
Catheter Precision develops products for cardiac electrophysiology and also owns private-aviation charter operations acquired through FLYTE. The company therefore operates through two distinct segments.
VIVO Cardiac Mapping System
VIVO is a non-invasive three-dimensional mapping system used to localize the origin of ventricular arrhythmias before an electrophysiology procedure. The technology combines a standard electrocardiogram with cardiac imaging data.
LockeT Suture Retention Device
LockeT temporarily secures sutures used to close vascular access sites after catheter-based procedures. Its design distributes tension and helps clinicians find and remove the suture efficiently.
Electrophysiology Commercial Model
VIVO is sold to hospitals and electrophysiology centers, while LockeT is a single-use product that can generate recurring procedure-based demand. U.S. direct activity and international distributors support commercialization.
Private Aviation Segment
Through acquired subsidiaries, the company provides private-aircraft charter services. This segment diversifies revenue but is operationally separate from the cardiac-device business.
未来催化剂
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。